Jpmorgan Clav Regulatory News (JCH)

RNS Number : 1253H

JPMorgan Claverhouse IT PLC

01 May 2025

 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

JPMORGAN CLAVERHOUSE INVESTMENT TRUST PLC

(the 'Company')

 

DIRECTORATE AND BOARD COMMITTEE CHANGES

 

Legal Entity Identifier: 549300NFZYYFSCD52W53

As previously announced in the Company's 2024 Annual Report and Financial Statements and following the Annual General Meeting of the Company, which was held today, the Company confirms that David Fletcher has retired from the Board to be replaced by Victoria Stewart as Chair with effect from 1st May 2025. Joanne Fintzen has assumed the role of Chair of Remuneration Committee from Victoria.

 

The Board would like to thank David Fletcher for his wise counsel and valuable contribution to the Company during his tenure.

 

 

The composition of all the Board committees is as follows:

 

Director		Audit Committee	Management Engagement Committee	Nomination Committee	Remuneration Committee
Victoria Stewart*		Attends by invitation	Member	Member	Member
Jill May**		Member	Chair	Chair	Member
Nicholas Melhuish		Chairman	Member	Member	Member
Joanne Fintzen		Member	Member	Member	Chair

Tom Smethers Member Member Member Member

 

*Board Chair

**Senior Independent Director

 

1st May 2025

For further information, please contact:

 

 

Anmol Dhillon For and on behalf of JPMorgan Funds Limited, Company Secretary Telephone 0800 20 40 20 (or +44 1268 44 44 70 )

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.